MD HB962 | 2019 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on February 8 2019 - 25% progression
Action: 2019-02-19 - Hearing 3/14 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring the Maryland Medical Assistance Program, subject to the limitations of the State budget, to provide coverage for any medically appropriate drug that is approved by the United States Food and Drug Administration for the treatment of hepatitis C and that is determined to be necessary by the treating physician of the Program recipient.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Maryland Medical Assistance Program - Coverage - Hepatitis C Drugs

Sponsors


History

DateChamberAction
2019-02-19HouseHearing 3/14 at 1:00 p.m.
2019-02-08HouseFirst Reading Health and Government Operations

Subjects


Maryland State Sources


Bill Comments

feedback